EX-23.1 6 otlk-20240930xex23d1.htm EX-23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the registration statements (Nos. 333-211362, 333-216081, 333-223064, 333-229685, 333-234024, 333-236471, 333-238318, 333-254777, 333-262731, 333-269770, 333-278343 and 333-281549) on Form S-8 and (Nos. 333-222387, 333-223063, 333-273979, 333-278209, 333-278340 and 333-278959) on Form S-3 of our report dated December 27, 2024, with respect to the consolidated financial statements of Outlook Therapeutics, Inc.

/s/ KPMG LLP

Philadelphia, Pennsylvania

December 27, 2024